Return to homepagePandemic Pact

Elucidation of SARS-CoV-2 and influenza virus transmission mechanism

Grant number: 21H03184

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2024

  • Known Financial Commitments (USD)

    $156,780

  • Funder

    KAKENHI

  • Principal Investigator

    Takaaki Nakaya Unspecified

  • Research Location

    Japan

  • Lead Research Institution

    Kyoto Prefectural Medical University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein.

Chimeric Newcastle Disease Virus Vectors Expressing Human IFN-γ Mediate Target Immune Responses and Enable Multifaceted Treatments.